Pillar-1: Multicenter Phase 2 Study of Everolimus for Patients with Mantle Cell Lymphoma Who Are Refractory or Intolerant to Bortezomib.
| Autor: | Wang, Michael, Popplewell, Leslie *, Collins, Robert H., Jr. *, Winter, Jane N., Goy, Andre, Robeva, Anna *, Pirotta, Nicoletta *, Fan, Jenna *, Klimovsky, Judith, O'Connor, Owen A. * |
|---|---|
| Zdroj: | In Blood 16 November 2012 120(21):2751-2751 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|